[BIOL] Biolase, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 1.61 Change: 0.03 (1.9%)
Ext. hours: Change: 0 (0%)

chart BIOL

Refresh chart

Strongest Trends Summary For BIOL

BIOL is in the long-term down -69% below S&P in 13 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: BIOLASE, Inc., a biomedical company, develops, manufactures, and markets lasers in dentistry and medicine in the Unites States and internationally. The company offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. The company also markets and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, and in-office, chair-side milling machines and three-dimensional printers, as well as provides precision intuitive diagnosis and treatment planning solutions. In addition, it offers medical systems comprising Diolase 10 Diode Laser for therapeutic applications consisting of temporary pain relief; topical heating for the purpose of te

Fundamental Ratios
Shares Outstanding EPS-0.27 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 6.57% Sales Growth - Q/Q-18% P/E-4
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-35.61% ROE-52.45% ROI
Current Ratio3.11 Quick Ratio2.27 Long Term Debt/Equity Debt Ratio0.42
Gross Margin37.11% Operating Margin-39.51% Net Profit Margin-41.44% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-230 K Cash From Operating Activities-7.4 M Gross Profit3.15 M
Net Profit-5.44 M Operating Profit-5.26 M Total Assets54.69 M Total Current Assets48.97 M
Total Current Liabilities15.76 M Total Debt380 K Total Liabilities17.57 M Total Revenue10.86 M
Technical Data
High 52 week2.78 Low 52 week0.39 Last close1.86 Last change-7.46%
RSI38.05 Average true range0.14 Beta0.65 Volume32.31 K
Simple moving average 20 days-13.16% Simple moving average 50 days-17.07% Simple moving average 200 days0.45%
Performance Data
Performance Week-8.82% Performance Month-12.26% Performance Quart-13.49% Performance Half39.85%
Performance Year232.14% Performance Year-to-date-2.62% Volatility daily4.87% Volatility weekly10.9%
Volatility monthly22.33% Volatility yearly77.36% Relative Volume99.99% Average Volume34.49 K
New High New Low

News

2020-05-19 06:31:37 | Analysts Have Just Cut Their BIOLASE, Inc. NASDAQ:BIOL Revenue Estimates By 11%

2020-05-10 08:36:30 | BIOLASE, Inc. NASDAQ:BIOL First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

2020-05-08 18:29:34 | Edited Transcript of BIOL earnings conference call or presentation 7-May-20 8:30pm GMT

2020-05-05 09:00:00 | Waterlase Dental Laser Meets Suggested Guidelines to Minimize Risk of COVID-19 Transmission Through Reduced Aerosol Production

2020-04-08 17:24:25 | Biolase partners with medical equipment maker on coronavirus ventilators

2020-04-08 11:17:00 | BIOLASE Partners with Intensive Care Unit Equipment Manufacturer MEKICS to Manufacture and Supply Ventilators in Response to the COVID-19 Pandemic

2020-03-31 10:56:10 | Edited Transcript of BIOL earnings conference call or presentation 26-Mar-20 8:30pm GMT

2020-03-31 06:30:40 | Things Look Grim For BIOLASE, Inc. NASDAQ:BIOL After Today's Downgrade

2020-03-29 08:47:27 | Earnings Update: BIOLASE, Inc. NASDAQ:BIOL Just Reported And Analysts Are Trimming Their Forecasts

2020-03-26 16:05:00 | BIOLASE Reports 2019 Fourth Quarter; Net Revenue Increased 18% Sequentially

2020-03-26 14:30:00 | BIOLASE, Inc. to Host Earnings Call

2020-03-24 09:00:00 | BIOLASE Announces Regulatory Clearance of Laser Bacterial Reduction Therapy Indication for Epic Hygiene Laser

2020-03-19 14:30:00 | BIOLASE, Inc. to Host Earnings Call

2020-03-18 16:05:00 | BIOLASE Reschedules Fourth Quarter 2019 Earnings Call To March 26, 2020

2020-03-12 16:05:00 | BIOLASE, Inc. to Report Fourth Quarter 2019 Results on March 19, 2020

2020-01-21 05:47:58 | Some BIOLASE NASDAQ:BIOL Shareholders Have Taken A Painful 94% Share Price Drop

2019-12-09 09:00:00 | BIOLASE Announces Clearance of the Epic Hygiene Laser for Dental Hygienists

2019-11-26 06:30:00 | BIOLASE Announces Schedule Of Investor Conferences In December

2019-11-15 06:30:00 | BIOLASE Appoints Michael DiTolla, DDS, FAGD To Its Board Of Directors

2019-11-07 17:37:49 | Edited Transcript of BIOL earnings conference call or presentation 6-Nov-19 9:30pm GMT

2019-11-06 16:05:00 | BIOLASE Reports Third Quarter 2019 Results

2019-10-31 17:00:00 | BIOLASE Secures $3 Million Revolving Line Of Credit

2019-10-24 21:35:00 | BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock

2019-10-23 09:00:00 | BIOLASE Wraps Inaugural Advancing Dentistry Symposium

2019-10-21 07:00:00 | BIOLASE Announces Select Preliminary Third Quarter 2019 Financial Results And Date For Reporting Third Quarter 2019 Results

2019-10-15 09:00:00 | BIOLASE Announces First-Ever U.S. & Canada Regulatory Clearance of Laser Crown and Veneer Removal

2019-08-28 07:30:00 | BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019

2019-08-09 13:10:22 | Edited Transcript of BIOL earnings conference call or presentation 8-Aug-19 8:30pm GMT

2019-08-08 16:05:00 | BIOLASE Reports Second Quarter 2019 Results

2019-08-05 07:00:00 | BIOLASE, Inc. to Report Second Quarter 2019 Results on August 8, 2019

2019-07-08 09:13:01 | Here's Why You Should Invest in Wright Medical Stock Now

2019-07-05 09:25:01 | Will MedTech Ease Investors' Concern & Outperform? 4 Picks

2019-05-29 16:05:00 | BIOLASE to Present at 9th Annual LD Micro Invitational Investor Conference

2019-05-16 07:58:00 | BIOLASE Announces Advancing Dentistry Symposium

2019-05-10 14:19:58 | Edited Transcript of BIOL earnings conference call or presentation 9-May-19 8:30pm GMT

2019-05-09 18:12:31 | Biolase: 1Q Earnings Snapshot

2019-05-09 16:05:00 | BIOLASE Reports First Quarter 2019 Results

2019-05-06 07:00:00 | BIOLASE, Inc to Report First Quarter 2019 Results on May 9, 2019

2019-04-09 08:00:00 | BIOLASE and TeamSmile Expand Initiative of Oral Health Day to Students in Kansas City Public Schools

2019-03-27 08:00:00 | BIOLASE, TeamSmile and Los Angeles Chargers to Host Oral Health Fair for Students from Los Angeles Public Schools

2019-03-12 08:45:00 | LD Micro Virtual Conference Is Live, March 12th and 13th

2019-03-11 07:00:00 | BIOLASE to Present at the 2019 LD Micro Virtual Investor Conference

2019-03-08 13:48:11 | Biolase Inc BIOL Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-03-06 00:31:41 | Edited Transcript of BIOL earnings conference call or presentation 5-Mar-19 9:30pm GMT

2019-03-05 16:05:00 | BIOLASE Reports 2018 Fourth Quarter and Full Year Results

2019-03-05 14:30:00 | BIOLASE, Inc. to Host Earnings Call

2019-02-28 08:00:00 | BIOLASE Inc. and Sinclair Dental Co. Ltd. Announce Canadian Distribution Agreement

2019-02-07 07:00:00 | BIOLASE, Inc to Report Fourth Quarter 2018 Results on March 5, 2019

2019-02-04 08:00:00 | Dallas Mavericks, BIOLASE, and TeamSmile Join Forces to Provide Free Dental Care to Kids from Dallas ISD and The Boys & Girls Club of Greater Dallas

2019-01-29 08:00:00 | BIOLASE, Inc. and Hu-Friedy Announce Joint Product Promotion at Upcoming Major 2019 Dental Meetings